Accordingly, we conducted the present study to test the effects of APOB variants on lipid profiles, metabolic syndrome, and the risk of DM in Taiwanese individuals by applying the candidate variant approach and regional association analysis to the data of over 110,000 individuals selected from the Taiwan Biobank (TWB) [15,16]. This evidence concerns the gene APOB and metabolic syndrome.